Home » Stocks » INMD

InMode Ltd. (INMD)

Stock Price: $74.08 USD 5.29 (7.69%)
Updated May 14, 2021 4:00 PM EDT - Market closed
After-hours: $74.10 +0.02 (0.03%) May 14, 7:59 PM
Market Cap 2.83B
Revenue (ttm) 231.19M
Net Income (ttm) 95.24M
Shares Out 38.19M
EPS (ttm) 1.16
PE Ratio 63.92
Forward PE 25.64
Dividend n/a
Dividend Yield n/a
Trading Day May 14
Last Price $74.08
Previous Close $68.79
Change ($) 5.29
Change (%) 7.69%
Day's Open 70.00
Day's Range 69.52 - 74.31
Day's Volume 894,568
52-Week Range 24.76 - 92.38

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Shareholders of Builders FirstSource Inc (BLDR, Financial), Deckers Outdoor Corp (DECK, Financial) and InMode Ltd (INMD, Financial) saw the value of their assets increase significantly in recent years, ...

Other stocks mentioned: BLDR, DECK
1 week ago - GuruFocus

YOKNEAM, Israel, May 5, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced consolidated financial results for its f...

1 week ago - PRNewsWire

InMode's (INMD) Morpheus8 Platform and Morpheus8 Body that use RF fractional technology are expected to have continued to contribute to the company's Q1 top line.

2 weeks ago - Zacks Investment Research

YOKNEAM, Israel, April 12, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results...

1 month ago - PRNewsWire

YOKNEAM, Israel, March 30, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced Mr.

1 month ago - PRNewsWire

Every Friday, at 3 p.m. ET, Ritholtz Wealth Management CEO Josh Brown and Benzinga CEO Jason Raznick host "The Boiler Room," a Clubhouse audio chat where listeners can pitch their favorite stock.

Other stocks mentioned: SPCE, STNE, AI, CARR, EXPE, TPL, TRIP ...
1 month ago - Benzinga

MedTech stocks like INMD, BASI and SMLR are expected to maintain market-beating momentum in 2021.

Other stocks mentioned: BASI, DGX, HOLX, LH, RMD, SMLR
1 month ago - Zacks Investment Research

YOKNEAM, Israel, March 16, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has filed a complaint with the United States International Trade...

2 months ago - PRNewsWire

Those looking for growth stocks to watch are always trying to discover top stocks making bullish moves amid rising profit estimates. Here are some ideas.

Other stocks mentioned: GNRC, HZNP, SIVB, WSM
2 months ago - Investors Business Daily

InMode also held up above its fast-climbing 50-day moving average, a good sign for now. The post Growth Stocks Take A Shellacking; Is It Time To Lock In Profits In InMode, 360 DigiTech?

2 months ago - Investors Business Daily

InMode (INMD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

2 months ago - Zacks Investment Research

InMode (INMD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down ...

2 months ago - Zacks Investment Research

The best stocks to buy and watch often show increasing fund ownership. That's why Celsius Holdings, InMode and Rio Tinto should be on your radar.

Other stocks mentioned: RIO
2 months ago - Investors Business Daily

Shares of InMode (NASDAQ:INMD) fell 0.1% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 104.35% over the past year to $0.94, which beat the e...

3 months ago - Benzinga

YOKNEAM, Israel, Feb. 10, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced consolidated financial results for its...

3 months ago - PRNewsWire

InMode's (INMD) Morpheus8 Platform and Morpheus8 Body that use RF fractional technology are expected to have contributed to the company's Q4 top line.

3 months ago - Zacks Investment Research

Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.

Other stocks mentioned: AZRE, HEES, KEP, MLI
4 months ago - Zacks Investment Research

YOQNEAM, Israel, Jan. 6, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced it will present a corporate social responsibility (CSR) ...

4 months ago - PRNewsWire

InMode is an outperformer and leader in the growing medical aesthetic devices industry. Its products are made for a variety of purposes including liposuction, skin rejuvenation, cellulite treatment, and...

4 months ago - Seeking Alpha

Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.

Other stocks mentioned: FCAU, MCRI, NPO, PIPR
4 months ago - Zacks Investment Research

Is (INMD) Outperforming Other Medical Stocks This Year?

5 months ago - Zacks Investment Research

InMode (INMD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

5 months ago - Zacks Investment Research

Is (INMD) Outperforming Other Medical Stocks This Year?

5 months ago - Zacks Investment Research

InMode has seen a tough first and second quarter for obvious reasons, yet remained incredibly profitable. Net cash balances never put the viability of the company in doubt as valuations were far too low...

6 months ago - Seeking Alpha

InMode Ltd. (INMD) CEO Moshe Mizrahy on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

YOKNEAM, Israel, Nov. 12, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced consolidated financial results for its...

6 months ago - PRNewsWire

Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like Catalyst Biosciences (CBIO), UFP Industries (UFPI), VeriSign (VRSN), InMode (INMD) and Castle Bi...

Other stocks mentioned: CBIO, CSTL, UFPI, VRSN
6 months ago - Zacks Investment Research

Technology won't always be on top. There's a bunch of budding industries that could prove to be winners over the next 5 years.

Other stocks mentioned: EXAS, QQQ, VCEL, XLK
6 months ago - Zacks Investment Research

YOKNEAM, Israel, Nov. 2, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that Mr. Moshe Mizrahy, Chairman and Chief Executi...

6 months ago - PRNewsWire

Find Strong Stocks with this New Analyst Coverage Screener

Other stocks mentioned: GRBK
6 months ago - Zacks Investment Research

Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like Perion (PERI), Live Oak (LOB), LexinFintech (LX) and InMode (INMD).

Other stocks mentioned: LOB, LX, PERI
6 months ago - Zacks Investment Research

LAKE FOREST, Calif., Oct. 20, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to introduce to the market the Morpheus...

6 months ago - PRNewsWire

The cosmetic device maker's sales rebounded sharply in the third quarter.

7 months ago - The Motley Fool

These three health-related businesses are well positioned to provide market-beating gains.

Other stocks mentioned: COLL, PFE
7 months ago - The Motley Fool

InMode is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

7 months ago - Zacks Investment Research

The medical device maker announced a million-share repurchase program.

8 months ago - The Motley Fool

Growth stocks have been the market's biggest winners. Amid valuation concerns, these 10 stocks still have the potential for 100%-plus gains.

Other stocks mentioned: APHA, CRWD, FSLY, PGNY, PINS, REAL, ROKU ...
8 months ago - InvestorPlace

InMode went public in August, 2019, raising $70 million.

9 months ago - Seeking Alpha

LAKE FOREST, Calif., Aug. 13, 2020 /PRNewswire/ -- InMode Ltd.

9 months ago - PRNewsWire

InMode Ltd. (INMD) CEO Moshe Mizrahy on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

YOKNEAM, Israel, Aug. 5, 2020 /PRNewswire/ -- InMode Ltd.

9 months ago - PRNewsWire

YOKNEAM, Israel, Aug. 3, 2020 /PRNewswire/ -- InMode Ltd.

9 months ago - PRNewsWire

LAKE FOREST, Calif., July 27, 2020 /PRNewswire/ -- InMode Ltd.

9 months ago - PRNewsWire

InMode (INMD) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.

10 months ago - Zacks Investment Research

The medical device maker's boosting its second-quarter guidance.

10 months ago - The Motley Fool

InMode (INMD) closed the most recent trading day at $28.07, moving +0.36% from the previous trading session.

10 months ago - Zacks Investment Research

InMode (INMD) closed at $31.15 in the latest trading session, marking a +1.1% move from the prior day.

10 months ago - Zacks Investment Research

In the latest trading session, InMode (INMD) closed at $31.15, marking a -1.61% move from the previous day.

10 months ago - Zacks Investment Research

InMode: A Look Into The Fundamentals Reveals A Clear Undervaluation

11 months ago - Seeking Alpha

InMode Ltd. (INMD) CEO Moshe Mizrahy on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

About INMD

InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of... [Read more...]

Industry
Medical Devices
IPO Date
Aug 8, 2019
Stock Exchange
NASDAQ
Ticker Symbol
INMD
Full Company Profile

Financial Performance

In 2020, InMode's revenue was $206.11 million, an increase of 31.81% compared to the previous year's $156.36 million. Earnings were $75.03 million, an increase of 22.71%.

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for InMode stock is "Strong Buy." The 12-month stock price forecast is 99.67, which is an increase of 34.54% from the latest price.

Price Target
$99.67
(34.54% upside)
Analyst Consensus: Strong Buy